Counseled client Alcon, Inc., a major medical device/pharmaceutical company in the eye care space, on IP due diligence matters for their acquisition of LenSx. Alcon purchased LenSx for $361 million plus maximum contingent payments of $382 million.
Alcon Acquisition of LenSx
Participating Lawyers
